The study, which will be published December 21 in the Journal of Cell Biology, suggests that the loss of these particular Numb proteins makes breast cancers more aggressive and resistant to chemotherapy, but points the way
toward new therapeutic approaches that could improve patient outcome by preserving p53 levels.
Not exact matches
During his twelve years at a child guidance center in Rochester,
New York, his
therapeutic orientation changed from a formal, directive
approach toward what became client - centered therapy.
Our findings shed
new light on the molecular mechanisms through which LA induces antiproliferative and pro-apoptotic responses in both breast and endometrial cancer cells
toward its usefulness in more comprehensive
therapeutic approaches.